4-amino-2-cyclopentene-1-methanol
AssigneeBurroughs Wellcome Co.
InventorSusan M. Daluge
Life of this patent
Estimating the term…
Abstract
The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. The invention also relates to pharmaceutical formulations and processes for the preparation of compounds according to the invention.
Claims4
(1S,4R)-4-Amino-2-cyclopentene-1-methanol substantially free of the corresponding (1R,4S) enantiomer.
(1R,4S)-4-Amino-2-cyclopentene-1-methanol substantially free of the corresponding (1S,4R) enantiomer.
The dibenzoyl-D-tartrate salt of (1S,4R)-4-Amino-2-cyclopentene-1-methanol substantially free from the corresponding (1R,4S) enantiomer.
The dibenzoyl-L-tartrate salt of (1R,4S)-4-Amino-2-cyclopentene-1-methanol substantially free of the corresponding (1S,4R) enantiomer.
Dependencies are inferred from the claim text.